XML 38 R18.htm IDEA: XBRL DOCUMENT v3.20.1
Note 13 - Income Taxes
3 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
13
.
Income Taxes 
 
The Company’s provision for income taxes consists of federal and state taxes, as applicable, in amounts necessary to align the Company’s year-to-date tax provision with the effective rate that it expects to achieve for the full year. Each quarter the Company updates its estimate of the annual effective tax rate and records cumulative adjustments as necessary.
 
On
March 27, 2020,
the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) was enacted in response to the COVID-
19
pandemic.  Under ASC
740,
the effects of changes in tax rates and laws are recognized in the period which the new legislation is enacted.  The CARES Act made various tax law changes including among other things (i) increased the limitation under IRC Section
163
(j) for
2019
and
2020
to permit additional expensing of interest (ii) enacted a technical correction so that qualified improvement property can be immediately expensed under IRC Section
168
(k) and (iii) made modifications to the federal net operating loss rules including permitting federal net operating losses incurred in
2018,
2019,
and
2020
to be carried back to the
five
preceding taxable years in order to generate a refund of previously paid income taxes (iv) enhanced recoverability of AMT tax credit carryforwards. As a result of the CARES Act, the Company recorded a discrete income tax benefit of approximately
$19,000
related to a reduction in
2019
state and local taxes as a result of increased deductions and recorded a balance sheet reclassification to reflect an income tax receivable of
$0.7
million related to the accelerated recoverability of AMT credit carryforwards with a corresponding reduction to the Company’s deferred tax assets.
 
For the 
three
months ended
March 31, 2020
and
2019
, we incurred pre-tax (loss)/income of (
$11.6
) million and 
$2.1
million, respectively, and a corresponding income tax benefit (provision) of
$2.7
 
million and (
$0.5
) million, respectively. 
 
The effective tax rate for the
three
months ended
March 31, 2020
 was
23.3%
compared to
23.7%
in the comparable prior period. The effective tax rate for the
three
months ended
March 31, 2020
and
2019
 differs from the U.S. statutory rate of
21%
primarily as a result of non-deductible executive compensation under IRC Section
162
(m) and a non-taxable adjustment for the fair market value of the Warrant.